230 related articles for article (PubMed ID: 33049302)
1. Stimuli-responsive and cellular targeted nanoplatforms for multimodal therapy of skin cancer.
Padya BS; Pandey A; Pisay M; Koteshwara KB; Chandrashekhar Hariharapura R; Bhat KU; Biswas S; Mutalik S
Eur J Pharmacol; 2021 Jan; 890():173633. PubMed ID: 33049302
[TBL] [Abstract][Full Text] [Related]
2. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery.
Cheng R; Meng F; Deng C; Klok HA; Zhong Z
Biomaterials; 2013 May; 34(14):3647-57. PubMed ID: 23415642
[TBL] [Abstract][Full Text] [Related]
3. Nanosystems Based on Magnetic Nanoparticles and Thermo- or pH-Responsive Polymers: An Update and Future Perspectives.
Mai BT; Fernandes S; Balakrishnan PB; Pellegrino T
Acc Chem Res; 2018 May; 51(5):999-1013. PubMed ID: 29733199
[TBL] [Abstract][Full Text] [Related]
4. Stimuli responsive and receptor targeted iron oxide based nanoplatforms for multimodal therapy and imaging of cancer: Conjugation chemistry and alternative therapeutic strategies.
Dhas N; Kudarha R; Pandey A; Nikam AN; Sharma S; Singh A; Garkal A; Hariharan K; Singh A; Bangar P; Yadhav D; Parikh D; Sawant K; Mutalik S; Garg N; Mehta T
J Control Release; 2021 May; 333():188-245. PubMed ID: 33766690
[TBL] [Abstract][Full Text] [Related]
5. Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: Role of surface engineered nanocarriers.
Gopalan D; Pandey A; Udupa N; Mutalik S
J Control Release; 2020 Mar; 319():183-200. PubMed ID: 31866505
[TBL] [Abstract][Full Text] [Related]
6. Stimulus Sensitive Smart Nanoplatforms: An Emerging Paradigm for the Treatment of Skin Diseases.
Divya ; Kaur G
Curr Drug Deliv; 2019; 16(4):295-311. PubMed ID: 30674258
[TBL] [Abstract][Full Text] [Related]
7. Pullulan based stimuli responsive and sub cellular targeted nanoplatforms for biomedical application: Synthesis, nanoformulations and toxicological perspective.
Raychaudhuri R; Naik S; Shreya AB; Kandpal N; Pandey A; Kalthur G; Mutalik S
Int J Biol Macromol; 2020 Oct; 161():1189-1205. PubMed ID: 32504712
[TBL] [Abstract][Full Text] [Related]
8. Janus Gold Triangle-Mesoporous Silica Nanoplatforms for Hypoxia-Activated Radio-Chemo-Photothermal Therapy of Liver Cancer.
Wang Z; Chang ZM; Shao D; Zhang F; Chen F; Li L; Ge MF; Hu R; Zheng X; Wang Y; Dong WF
ACS Appl Mater Interfaces; 2019 Sep; 11(38):34755-34765. PubMed ID: 31474108
[TBL] [Abstract][Full Text] [Related]
9. Stimuli-Responsive Polymeric Nanoplatforms for Cancer Therapy.
Chang D; Ma Y; Xu X; Xie J; Ju S
Front Bioeng Biotechnol; 2021; 9():707319. PubMed ID: 34249894
[TBL] [Abstract][Full Text] [Related]
10. Stimuli-responsive nanoplatforms for antibacterial applications.
Huang Y; Zou L; Wang J; Jin Q; Ji J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1775. PubMed ID: 35142071
[TBL] [Abstract][Full Text] [Related]
11. Stimulus-responsive targeted nanomicelles for effective cancer therapy.
Muthu MS; Rajesh CV; Mishra A; Singh S
Nanomedicine (Lond); 2009 Aug; 4(6):657-67. PubMed ID: 19663594
[TBL] [Abstract][Full Text] [Related]
12. Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.
Sun Y; Davis E
Nanomaterials (Basel); 2021 Mar; 11(3):. PubMed ID: 33809633
[TBL] [Abstract][Full Text] [Related]
13. Stimulus-Responsive Nanomedicines for Disease Diagnosis and Treatment.
Liu G; Lovell JF; Zhang L; Zhang Y
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887466
[TBL] [Abstract][Full Text] [Related]
14. Chitosan-based nanosystems for cancer diagnosis and therapy: Stimuli-responsive, immune response, and clinical studies.
Moghaddam FD; Zare EN; Hassanpour M; Bertani FR; Serajian A; Ziaei SF; Paiva-Santos AC; Neisiany RE; Makvandi P; Iravani S; Xu Y
Carbohydr Polym; 2024 Apr; 330():121839. PubMed ID: 38368115
[TBL] [Abstract][Full Text] [Related]
15. Nanostructures for pH-sensitive Drug Delivery and Magnetic Resonance Contrast Enhancement Systems.
Sun X; Zhang G; Wu Z
Curr Med Chem; 2018; 25(25):3036-3057. PubMed ID: 28393692
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species responsive nanoplatforms as smart drug delivery systems for gastrointestinal tract targeting.
Bertoni S; Machness A; Tiboni M; Bártolo R; Santos HA
Biopolymers; 2020 Jan; 111(1):e23336. PubMed ID: 31724750
[TBL] [Abstract][Full Text] [Related]
17. The Smart Drug Delivery System and Its Clinical Potential.
Liu D; Yang F; Xiong F; Gu N
Theranostics; 2016; 6(9):1306-23. PubMed ID: 27375781
[TBL] [Abstract][Full Text] [Related]
18. Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies.
Tian H; Zhang T; Qin S; Huang Z; Zhou L; Shi J; Nice EC; Xie N; Huang C; Shen Z
J Hematol Oncol; 2022 Sep; 15(1):132. PubMed ID: 36096856
[TBL] [Abstract][Full Text] [Related]
19. Stimulus-Responsive Drug Delivery Nanoplatforms for Osteoarthritis Therapy.
Jiang Q; Zhang S
Small; 2023 Jun; 19(23):e2206929. PubMed ID: 36905239
[TBL] [Abstract][Full Text] [Related]
20. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.
Baeza A; Colilla M; Vallet-Regí M
Expert Opin Drug Deliv; 2015 Feb; 12(2):319-37. PubMed ID: 25421898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
